CXCL13 antibody for the treatment of autoimmune disorders.

BMC Immunol · 2015 · PMC4329654 · PMID 25879435

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

As shown in Figure 4 , migration of CFSE-labeled donor B cells into recipient spleens showed a trend to being reduced in MAb 5261-muIg-treated animals, indicating that this anti-CXCL13 specific antibody impedes B cell homing to a secondary lymphoid organ.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.